Big Pharma’s Dirty Little Secret: Vaccine-Induced Autoimmune Injury#Truth#Real#Pregnancy

Written By: Celeste McGovern

May 17, 2016 GreenMedInfo LLC. This work is reproduced and distributed with the permission of GreenMedInfo LLC. Want to learn more from GreenMedInfo? Sign up for the newsletter here http://www.greenmedinfo.com/greenmed/newsletter.”

Nasal flu vaccine left  energetic and happy 10-year-old Bobby Hunter with disease that makes him afraid to smile.

Scientists reveal how a hyperactivated immune system can unleash disease

Bobby Hunter was 10 years old when his mother noticed her usually energetic boy was struggling to stay awake and he looked exhausted all the time. Then he began collapsing. Eventually Bobby was diagnosed with narcolepsy, a lifelong incurable condition where victims suddenly drop into deep dream sleep, sometimes a dozen times a day or more. It can be accompanied by bizarre and terrifying symptoms: waking hallucinations of demons, insomnia, sleep paralysis and a sudden loss of muscle control or cataplexy often triggered by strong emotions. Bobby now has to be accompanied everywhere he goes in case he falls unconscious; he’ll never bathe or drive or cross a street alone. But his case is particularly cruel. Now, he is a child who is afraid to smile or laugh because it might trigger an attack.

Bobby’s mother Amanda is adamant he first became ill after he received the nasal flu vaccine at his school. But could such a small thing cause such a devastating disorder?

Narcolepsy Nightmare Explained

This month at the 10th Autoimmunity Congress in Leipzig, Germany a leading pharmaceutical researcher presented his international team’s findings suggesting that vaccination could indeed have the “unexpected” effect of inducing crippling narcolepsy, an autoimmune disease.

Sohail Ahmed, lead author of a ground breaking paper published last summer in Science Translational Medicine explained how the now-retracted Pandemrix vaccine was implicated in a narcolepsy epidemic of more than 1,300 children in several European countries and spates of cases linked to other vaccines for the 2009 swine flu pandemic that never materialized.

It turns out,  part of the influenza nucleoprotein in the swine flu vaccine looked (molecularly) just like a receptor for a neurotransmitter in the brain called orexin that regulates the sleep/wake cycle, explained, Ahmed former global head of clinical sciences at Novartis and later GlaxoSmithKline who is currently with Roche Pharmaceuticals.

When the vaccine was injected with an adjuvant to ramp up the immune response, the immune system went into overdrive. Something  — maybe chemical ingredients in the vaccine, maybe inflammation  –  breached the blood brain barrier and the immune system targeting the vaccine virus also locked in on the receptors in the brain sleep centre. Narcoleptic patients’ own immune system then destroyed a hub of 70,000 or so orexin-producing cells in their brains before their hosts started knocking out. The autoimmune reaction can’t be turned off because the immune system is programmed to relentlessly attack anything it perceives as a foreign invader. It’s a case of mistaken identity and in immunology it’s called a “cross-reaction.”

But could other vaccines still in circulation that contain the H1N1 virus trigger narcolepsy too? Could the same mechanism cause kids like Bobby Hunter to get narcolepsy from the nasal flu vaccine?

Both Ahmed and immunologist Maria Teresa Arango at Leipzig confirmed that it could indeed. Bobby probably carries the HLA-DQB1*0602 genetic marker that leaves him at a higher risk of getting narcolepsy. But so does 20% of the US population. For pharmaceutical industry dependents like Ahmed, so long as cases like Bobby’s are not epidemic as they were with Pandemrix, they are collateral damage the pharmaceutical industry is willing continue to keep flu vaccines rolling.

But what if other vaccine proteins are acting in more unexpected ways, contributing to other autoimmune diseases?

Arango said such cross-reactivity could be the underlying mechanism for widely varied and unexpected documented vaccine adverse autoimmune events affecting other parts of the brain or body. She pointed to the work of Dr. Darja Kanduc.

Massive Peptide Sharing, Massive Autoimmunity?

Kanduc is a biochemist at the University of Bari in Italy who presented her findings in Leipzig at a one-day symposium on vaccine safety sponsored by the Children’s Medical Safety Research Institute. Bari has been looking for molecular similarities between microbial and human proteins and found that a massive, unexpected “peptide sharing” exists between human proteins and microbe proteins.

Where overlap (“peptide sharing”) occurs between a foreign protein and human protein, they have a same identical amino acid sequence (for example, SLVDTYR).  An immune response launched against SLVDTYR might hit A (the microbial protein) and also B (the human protein). In immunology terms, this is a cross-reaction between A and B — in the same way Ahmed’s team illustrated vaccine-induced narcolepsy.

Normally such cross-reactions do not occur, explains Kanduc. “In fact, the human immune system has been ‘educated’ to ignore foreign proteins and avoid cross-reactions in order not to harm the similar human ‘self’ proteins.” In immunology, this is called immunotolerance. Our immune system does not press the panic button and launch an attack on every foreign viral protein it encounters.

Tolerance Lost

Our natural immunotolerance has proved a big problem for vaccine manufacturers over the years. Simply injecting a viral or bacterial particle into our bodies does not trigger the immune storm they want. Our bodies aren’t designed to encounter pathogens via intramuscular injection, after all. Our immune system refuses to attack the injected pathogen since that would mean also attacking the look-alike human proteins. It would rather not go to war than risk the home casualties.

Imagine the immune system as a border guard. If a guard at the Canada-US border pulled every vehicle that drove up to his checkpoint aside, emptied the suitcases, called in the sniffer dogs, strip-searched the occupants and called for the SWAT team, things would get ugly pretty fast. Most of the time, border guards are alert but passive. Our immune system is the same way with foreign proteins.

So vaccine manufacturers pepper vaccines with adjuvants — crude extracts of mycobacteria, toxins such as mercury, aluminum salts, or mineral oils to force the reluctant immune system to go into attack mode – from passive border guard to hypervigilant nutter pulling a gun on a granny.  Celebrated Yale immunologist Charles Janeway called this “immunologist’s dirty little secret” underlying vaccination.

 “Adjuvants expand, potentiate, and increase immune responses,” explains Kanduc. “Such hyperactivation has a price: the loss of specificity. The hyper-stimulated immune system does not discriminate any more between foreign proteins and self-proteins…Adjuvants render the immune system blind. Human proteins that share peptide sequences will be attacked.”

Kanduc likens immunotolerance to a protective wall. “The dam is demolished by the adjuvants and the cross-reactivity flood can crush and alter human proteins.” This might also cause numerous cross-reactions, manifested as a wide variety of autoimmune attacks.

Can vaccines induce genetic disease?

Kanduc looked for peptide sharing between a single influenza A H5N1 protein and human proteins. She found that the viral protein shares 70 peptides with the human host — proteins involved in basic cell functions including proliferation, neurodevelopment, and differentiation.

Among the human proteins that could be on the firing range: reelin, a protein involved in neuron layering, neurexins, proteins that connect neurons,  syndrome 10 protein for Bardet-Biedl syndrome, a transcription factor for Williams Syndrome (a rare genetic neurodevelopmental disorder), a protein associated with amyotrophic lateral sclerosis, and so on.

When these human proteins are altered, as for example by genetic mutations, neurological disorders such as epilepsy, obesity, dystonia, amyotrophic lateral sclerosis, Sudden Infant Death Syndrome and demyelinating diseases like multiple sclerosis occur, says Kanduc.

 “The same spectrum of diseases might occur if these human proteins are attacked and altered by cross-reactions following an expanded and indiscriminate immune response induced by an adjuvant vaccine,” she adds.

With such “massive overlap” of proteins, the potential for vaccines to induce all sorts of autoimmune diseases is possible; it explains why such diverse autoimmune phenomena have been documented in the medical literature with respect to vaccination, from neurological disorders to skin afflictions to impaired fertility.

“The type of autoimmune phenomenon and disease that is eventually established will depend on the molecules and organs attacked,” explains Kanduc. “For example, attacks against myelin may evoke demyelinating diseases [such as multiple sclerosis] whereas immune reactions against proteins involved in behaviour  and /or cognition may cause autism and behaviour disorders.”

Autoimmune Infertility?

Such autoimmunity may be the mechanism underlying cases of premature menopause and infertility in adolescent girls following injection with the vaccine against HPV, described in Leipzig by an Australian GP. Deirdre Little, a general practitioner in South Bellingen, first published a case study of her 16-year-old patient who developed premature ovarian insufficiency (POI) following HPV vaccination. Since then Little has encountered six more post-HPV cases of sterility in adolescents in her practice – though primary ovarian insufficiency is almost unheard of  — normally affecting one in 100,000 girls under age 20.

Little and Harvey Ward, the Australian obstetrician gynaecologist who co-authored her studies, highlighted their concerns that the HPV vaccine’s impact on fertility has not been researched.

What’s more, she said:  “The ‘saline’ placebo control for this vaccine target group was not saline.” Little discovered that even product information was misleading on this point and failed to mention that the “placebo” for the HPV contained the toxic metal aluminium and polysorbate 80 – an ingredient which has exhibited delayed ovarian toxicity to rat ovaries at all injected doses tested over a tenfold range.

Polysorbate 80 has been compared to diethylstilbestrol (DES), a cancer drug given to women until 1971 when it was shown to induce cancer. Later researchers discovered children who were exposed to DES in utero also had high risk of cervical cancer and infertility.

“The definition of a safe drug is when the children of the people who have taken it can reproduce healthy children,”

said Ward. It will be a long time yet before the HPV vaccine can be declared safe.

Contraceptive researchers have been trying to make a birth control vaccine for decades – primarily by vaccinating against female hormones such as follicle stimulating hormone and human chorionic gonadotropin. They’ve been hampered by their inability to rein in the triggered immune system; besides FSH and HcG, it attacks look-alike sequences on hormones such as thyroid and leutenizing hormone.

 “Our goal with our vaccine was to develop autoimmunity,” Bonnie Dunbar, a 20-year veteran vaccine researcher, told the 4th International Public Conference on Vaccination in 2010, according to a report from the Population Research Institute. Dunbar tried to train rabbits’ immune systems to attack proteins on their ova using pig proteins in her vaccine to “trick the rabbit into inducing antibodies against its own self proteins.”

Instead, she inadvertently launched a full-scale immune assault that completely destroyed their ovaries. “Unfortunately, we weren’t just looking at preventing fertilization now,” said Dunbar, “we generated a complete autoimmune disease, which is also known as premature ovarian failure.”

Is it possible that components of HPV vaccines share sequences with components of the reproductive system?

Do Vaccines Create New Diseases?

In 2007 cattle farmers in Europe began reporting a bizarre new disease among calves. Sometimes the new-born animals were just found dead, but others, usually less than a month old, would develop nosebleeds, black tarry stools and high fevers. Sometimes ear tagging, or the slightest scratch or knock would lead to uncontrollable bleeding. Something appeared to be destroying platelets in the blood of these animals, and post mortems revealed massive internal bleeding and almost completely decimated bone marrow.

By 2009 the disease was in the UK, and while it usually only affected one or two animals on a given farm, sometimes it affected as many as 10 percent of new-borns and it was almost always lethal. Eventually it would kill at least 4,500 calves. Vets suspected many more cases were going unreported and there was no sign of the mystery abating. Veterinary agencies were growing alarmed. The first epidemiology reports in 2009 confirmed rumours: the new disease called Bleeding Calf Syndrome, or bovine neonatal pancytopenia in academic circles, had something to do with Pfizer’s new PregSure vaccine against bovine viral diarrhea (BVD). In 2010 the vaccine was pulled from the market.

BVD spreads easily among intensively farmed animals (not so much grass-fed), and it causes diarrhea, lowers milk production and can cause stillbirths. A calf infected in utero that survives can be persistently infected throughout its lifetime and keep the disease circulating. The PregSure vaccine was given to pregnant cows to avoid BVD transmission to developing calves.

But a host of studies conducted by European agriculture ministries and veterinary researchers revealed the underlying mechanism: the vaccine caused the dams to produce aggressive anti-viral antibodies, present in their colostrum, which also attacked the newborn calves’ blood cells when they drank them.

Today, six years after PregSure was discontinued, previously vaccinated dams are still producing bleeding calves.

Vaccines In Pregnancy

Bleeding Calf Syndrome raises a host of questions: What do these findings suggest for humans? What happens when pregnant women are vaccinated against foreign proteins? The CDC advises women to get vaccinated before, during and after pregnancy. Do these women pass on potentially cross-reactive antibodies to their babies as well?

It seems the industry is aware of the enormous implications of the phenomenon. A study published two months ago in the journal Vaccine states that,

“Although maternal vaccination is generally considered to be safe, the occurrence of Bovine Neonatal Pancytopenia (BNP) in cattle shows that maternal vaccination may pose a risk to the offspring.”

“The occurrence of BNP years after last PregSure© BVD vaccination indicates that alloantibody levels may remain high in dams,” it adds. Alloantibodies are immune system components that recognize and attack proteins with genetic differences within species – as between a host and a tissue transplant graft, for example. “Since pregnancy induces alloantibodies we hypothesized that pregnancy boosts the vaccine-induced alloantibody response,” explain the researchers from the Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine at Utrecht University in The Netherlands.

Pregnancy seems to reactivate the immune system and relaunch antibody production – in calf after calf. It also suggests that pregnancy is a particularly vulnerable window for launching autoimmune disease.

Subclinical Disease

You may be reassured to think only several thousand calves died from the PregSure vaccine, but recent veterinary studies have demonstrated that the bleeding calves are not all of the affected newborns. A 2014 study found that while only three percent of offspring expressed clinical bleeding calf syndrome, 15 percent of the clinically normal calves had “profoundly altered hematology.” Though they were not ill before they were sold, the researchers could not say if they would become so later or in different conditions.

What happens to the subclinical cows? Do they carry these alloantibodies for life and do they become clinically diseased with a stress trigger years later as per Autoimmune/inflammatory Syndrome Induced by Adjuvants?  Are they already experiencing subtle symptoms of disease? I contacted Zoetis Inc. the animal health company that Pfizer spun off in 2013, to ask these questions. They said they would get back to me. I’m still waiting.

Again, the questions about subclinical disease in animals are important for humans. Is it possible that there are subclinical manifestations of other vaccine adverse events?   Scientists have wondered if generalized anxiety and panic disorders might not be subclinical manifestations of narcolepsy, for example, because they also share symptoms of narcolepsy, such as cataplexy. Is it possible that H1N1 antibodies act subtly at lower levels but still have an effect on the brain? Is it possible that other vaccine proteins induce other autoimmune diseases in people with different susceptibilities?

These are questions that haven’t yet registered with public health vaccine advocates who sit in closed-door policy meetings and hold shares in the drugs they mandate. Bleeding calves won’t be on their radar for years, if ever. They still refuse to acknowledge that Pandemrix was linked to narcolepsy – though the industry does. And cases like Bobby Hunter?  Forget it.

Public health regulators’ main interest is preserving the notion that vaccines help more than they harm. Anything else is blasphemous.

For the rest of us, though, a recent review in immunology literature should give pause. It states: “To date, more than 80 systemic and organ-specific autoimmune diseases have been defined, and their cumulative burden is substantial, both medically and financially. Furthermore, the burden of autoimmune and autoinflammatory diseases is rising, making these diseases a ubiquitous global phenomenon that is predicted to further increase in the coming decades.”

An autoimmune storm is rising. The role of vaccines in it is emerging and will one day be crystal clear. The question is, how far off is that day, and who is going to pay while we wait for it?

Celeste McGovern is a national award-winning investigative journalist in the United Kingdom.

To view the scientific presentations from the 4th International Symposium on Vaccines, go to www.cmsri.org.

To explore more research related to the unintended, adverse effects of vaccination use the GreenMedInfo.com Vaccine Research portal.

Continue to the Article Here

Japan and the HPV Vaccine Controversy#Vaccines#HPV#Health

Japan and the HPV Vaccine Controversy
By Norma Erickson    SaneVax Inc
Beautiful flowering Japanese cherry - Sakura
The SaneVax Team would like to share a series of events in Japan which culminated in a decision which was nothing short of miraculous. This decision and the events leading up to it offer hope to millions of families whose lives have been adversely impacted by the use of Gardasil and Cervarix.

Due to massive efforts by HPV vaccine victims and their families, independent medical and scientific professionals willing to speak about their concerns, traditional media outlets with the integrity to investigate and report accurately, input and assistance from the SaneVax team, and political representatives who actually did the job they were elected to perform – THERE WILL BE NO GOVERNMENT RECOMMENDED HPV VACCINATION PROGRAM IN JAPAN FOR AT LEAST A YEAR.

Because all of the groups just mentioned worked together to preserve the health of Japanese girls, multiple members of the House of Councilors, the ruling Liberal Democratic Party intervened making it impossible for Japan’s Ministry of Health, Labor and Welfare to call for the re-instatement of Japan’s official recommendation for HPV vaccines (both Gardasil and Cervarix) for 2014.

Basically, the HPV vaccine debate in Japan came down to one side claiming psychosomatics versus the other side presenting science. Science won!

Timeline of Events Recorded by SaneVax:

 29 March 2013 – Japan decided to add both HPV vaccines, a pneumococcal vaccine and a vaccine for Japanese Encephalitis to their government recommended vaccination schedule. Although HPV vaccines had been approved for several years, they had not been widely used. The new law was to take effect April 1st. SaneVax received questions from a Tokyo newspaper journalist concerned about the safety of HPV vaccines the same day. This was quickly followed by inquiries from other journalists, both newspaper and television, as well as Japanese victims’ advocates.

 14 June 2013 – Japan suspended their recommendation for both HPV vaccines after discovering the adverse events reported after Gardasil and Cervarix were between 1.7 and 3.6 times higher than the other two vaccines which had just been added to the recommended schedule. The government wanted time to obtain a more complete picture of HPV vaccine side effects. This meant that medical consumers in Japan could still obtain HPV vaccines should they so desire, but prior to administration the provider had to inform the patient that the vaccine was NOT recommended by the government.

 18 June 2013 – Newspapers in Japan reported the government task force assigned to analyze reports of HPV vaccine injuries had examined 2,000 cases and found 357 of them to be serious. The Health Ministry decided there was no way to determine whether the vaccines were responsible for contributing to the new medical conditions at that time, so decided to conduct further studies and make a determination as to whether to reinstate its recommendation of HPV vaccines in about six months (a tentative deadline of mid-December).

 28 Sept 2013 – The Secretary General of the Nationwide Liaison Association of Cervical Cancer Vaccine Victims and Parents and a journalist from Kyoto News informed the SaneVax team that a delegation from the Ministry of Health was making plans to visit health officials in London and Washington DC as a part of a fact finding mission.

 3 Oct 2013 – The meetings scheduled with the United States health officials were postponed at the request of the U.S. government.

 7 Oct 2013 – As a result of intense negotiations between the Secretary General, a journalist from Kyoto News(who had agreed to act as an interpreter, and the SaneVax team, the Japanese Ministry of Health representative along with three esteemed Japanese medical professionals attended a meeting in London to gather evidence from Dr. Sin Hang Lee, MD, Pathologist, Milford Hospital, Director, Milford Medical Laboratory Inc., and former associate professor of pathology at Yale University; Professor Francois Jerome Authier, MD, PhD, Reference Center for Neuromuscular Disorders, Henri Mondor Hospital, Paris and Dr. Damien Downing, MB BS, MIBiol from London who is a pioneer of Ecological Medicine, Mrs. Freda Birrell, Secretary of SaneVax Inc. and her husband David Birrell, VAERS Research Analyst for SaneVax Inc. (Note: Conditions for this meeting were that all information presented be kept in strictest confidence until Mr. Miyamoto, Japan’s Ministry of Health, had time to return home and make his formal recommendations.)

 16 Oct 2013 – An article appeared in The Japan Times News – indicating the beginning of a full-scale investigation into the side effects from HPV vaccine use.

 28 Oct 2013 – Japan’s advisory committee on immunization policies met to decide whether to restart the HPV immunization program – the chief of the advisory board said the panel will put forward its final advice to the health ministry in December.

 30 Nov 2013 – It was revealed that the meeting with the same Japanese delegation originally scheduled to take place in the United States had occurred in secret between November 20 and 22 with no input from any experts independent of pharmaceutical industry influence. Rumors were circulating in Japan that the health authorities intended to announce a recommendation to re-start HPV vaccination programs on December 22 with an official announcement coming out on December 25. At this time, the advisory committee was believed to be split 70% for and 30% against making such a recommendation.

 16 Dec 2013 – Senator Yamatani had obtained the scientific evidence provided to Mr. Miyamoto in London and pulled together top medical professionals from Japan to analyze the data and explain it to her. Once explained, in addition to being concerned about the lack of need and unproven efficacy of HPV vaccines, she was seriously concerned about their safety.

 The December 25th deadline passed with no official word from the Japanese Health Ministry. This left the Ministry of Health in an awkward position. The fiscal year for Japan’s government began on April 1st. If no determination was made prior to that date – there would be no government recommended HPV vaccination program.

 20 Jan 2014 – The Japanese government’s advisory council released an official report in which they dismissed all of the symptoms that have shown up in the vaccinated girls as the consequences of psychogenetic psychosomatic reactions. According to Kyoto News Reporter, Mutsuo Fukushima, the key proponent of this theory of psychosomatic reaction is Dr. Yutaka Ohno of Keio University, who stated publicly: “It is impossible to find physical causes for the alleged and presumed adverse reactions at those vaccinated girls, so we cannot help, concluding that their so-called adverse reactions are the mere consequences of psychosomatic reactions. The government should provide counselling to the girls so that they may be freed from their psychosomatic reactions.”

 24 Jan 2014 – Due to the tireless efforts of all concerned, Senator Yamatani and Senator Nakagawa agreed to help facilitate an open debate on the benefits versus risks of HPV vaccines. The HPV vaccine proponents would represent one side of the debate and have the opportunity to choose which experts would represent them. Those concerned about the use of HPV were asked to gather experts from around the globe to testify as to the potential dangerous consequences and lack of need for mass HPV vaccination programs, and be available to answer questions from the audience. A tentative goal of mid-February was set for the debate to give each side time to secure experts.

 January to mid-February – Due to massive efforts behind the scenes, by the time the debate was scheduled the calendar of events also included a public Symposium on the Adverse Reactions experienced by girls after HPV vaccination, two televised press conferences, a debate on HPV vaccine risks versus benefits (open to the public and televised) and a briefing on HPV matters to influential lawmakers of the ruling Liberal Democratic Party.

 25 Feb 2014 – International Symposium on the Adverse Reactions experienced by girls who have been vaccinated with Human Papillomavirus Vaccines followed by Press Conference.

 26 Feb 2014 – Government Sponsored Public Hearing (debate) of the Health Ministry’s Advisory Council for the Deliberations on the Reported Adverse Events of HPV Vaccines, the advisory panel consisting of 15 scientists – February 26th, 10:00 to 11:30 a.m. (Evidence to be presented by scientists and medical professionals from the United States, Canada, France and Japan regarding potential mechanisms of action between HPV vaccines and serious adverse events.) Briefing on HPV Matters to Influential Lawmakers followed by a press conference. (Note: A synopsis of the scientific information presented is at the end of this article.)

 27 Feb 2014 – Word from Japan was that all events were well attended and well received. Major television broadcasters covered all of the public events. Newspaper articles for the most part portrayed accurate accounts of the proceedings. Doctors from all over Japan started writing letters stating that in their opinion it was outrageous for government health officials to try and explain away the girls’ new medical conditions as psychosomatic. Government officials began to sign on to a resolution supporting a complete ban on HPV vaccinations.

 26 March 2014 – The Ministry of Health, Labor and Welfare met to decide whether to make a recommendation to reinstitute the previously suspended government recommendation for HPV vaccines.

 The final deadline of April first passed with no official word from the Ministry of Health – leaving the government recommendation for HPV vaccines suspended for 2014.

This silence on the part of the Ministry of Health, Labor and Welfare speaks volumes. It means the voices of victims and their families has been heard. They will no longer have to worry about being told their symptoms are all in their head, coincidental, or just plain accidental.

For the next year (at least) women in Japan can get either Gardasil or Cervarix at no cost, should they so desire. The difference now is that it will be their decision to make – not one that is government mandated. If they decide they want to take these vaccines, their healthcare provider must inform them prior to administration that the vaccine is NOT recommended by the Japanese government.

This is a huge victory for every family around the globe who has suffered after participating in a global health experiment conducted in the name of cervical cancer prevention – HPV vaccination programs.
These events did not happen by accident. Japan’s decision was the culmination of a lot of hard work combined with valid scientific research, and these three factors:

1. The families of those who experienced adverse events after HPV vaccination did not surrender. In spite of their pain, they organized, spoke out and demanded action from their government health officials and political representatives.

2. Despite the intense pressure exerted on medical professionals to claim adverse events that occur after HPV vaccinations are the result of coincidence, mass hysteria, conversion disorder, psychogenic illness, fabricated illness, or genetic disorders, numerous medical professionals in Japan actually listened to their patients, investigated, and came to their own independent conclusions. Not only that, they had the courage to speak out for those who were suffering and demand investigations.

3. Japanese politicians had the integrity to listen to both sides of the HPV vaccine debate in public as well as privately.

Society can no longer justify sacrificing our children’s health and perhaps their very lives in the name of public health. The ‘greater good’ is no excuse – every single individual life is valuable – public health agencies need to start acting like it.

The time has come for physicians to establish diagnostic criteria for vaccine injuries. Scientists need to determine who is most likely to suffer an adverse reaction after vaccination and why. Most importantly, successful treatment protocols must be developed for the vaccine injured.

Above all – every country in the world needs to encourage open and honest scientific debate regarding HPV vaccines. Just think about it, If HPV vaccines are half as good as they claim to be – public debate should be no problem.

Medical and Scientific Evidence Submitted in Japan:

Dr. Authier (data presented at the public hearing, at the meeting with the Senators and at news conferences)

1) Aluminum salts used as adjuvants in HPV vaccines can cause myalgia, chronic fatigue syndrome, cognitive impairment, overt autoimmune disease, multiple sclerosis, DM, thyroiditis…)

2) Macrophagic myofasciitis, biopsy proven, is significantly associated with above conditions.

3) Alum particles can be transported by monocyte-lineage cells to lymph nodes, blood and spleen, and penetrate the blood brain barrier with potential damages to nerve tissues.

4) Aluminum salts are poorly biodegradable as adjuvant in HPV vaccines.

Dr. Hajjar (data presented at the meeting with the Senators and at news conferences, and admitted to public hearing through Dr. Sin Hang Lee)

1) Dr. Hajjar reported the case of a 16-year-old girl who suffered an acute-onset and permanent bilateral visual loss and a transient left hemiparesis following Gardasil vaccination.

2) Tumefactive demyelinating lesions and chiasmal neuritis as part of a presentation of acute demyelinating encephalomyelitis were documented by MRI imaging studies.

3) A brain biopsy was performed on this case to confirm that there was a perivascular infiltration of lymphocytes and macrophages with focal demyelination in the brain tissue, characteristic of the histopathological changes in acute demyelinating (or disseminated) encephalomyelitis as complication of vaccination.

Dr. Tomljenovich (data presented at the meeting with the Senators and news conferences)

1) Post-mortem brain tissue specimens from two young women who suffered from cerebral vasculitis-type symptoms following vaccination with the HPV vaccine Gardasil were analyzed by IHC for various immuno-inflammatory markers.

2) Gardasil-vaccinated cases showed positive immuno-reactivity for HPV-16L1 antigen in cells within cerebral vessels, with some HPV-16L1 – positive cells adhering to the walls of these vessels and some infiltrating the brain parenchyma. No such pattern of staining was observed with the anti-HPV-18L1 anti-HPV-11L1 antibody in any of the Gardasil-vaccinated cases. Control cases were negative.

3) Conclusions: The presence of foreign antigenic material in the central nervous system can trigger adverse inflammatory and immune-mediated manifestations. Normally, vaccine antigens are not expected to cross the blood-brain barrier. The finding of HPV-16L1 intra and perivascular immuno-positive cells in the brains of these two cases suffering unexpected and sudden death following Gardasil vaccination is thus of concern.

Dr. Lee (data presented at the public hearing, at the meeting with the Senators and at news conferences)

1) Gardasil contains residual HPV L1 gene rDNA fragments, firmly bound to the AAHS adjuvant by ligand exchange through the phosphate backbone of the DNA molecule in non-B conformation – a new chemical inadvertently created in the vaccine manufacturing process.

2) It is well known that aluminum nanoparticles can transfect foreign, bacterial or viral DNA into human cells, especially macrophages, and macrophages can cross the blood brain barrier.

3) It is well known that activated macrophages, highly immune-stimulated by free bacterial or viral DNA, can produce and release a variety of cytokines, including tumor necrosis factor which is a myocardial depressant and can cause acute inflammation. Human macrophages recognize HPV DNA as a viral DNA (foreign invader), not the DNA from the human host’s own body, and react in a high alert state- a highly augmented reaction which may be very harmful in certain genetically predisposed young girls. We cannot predict which girls will react violently in their heart and in their brain as a result of these activated macrophage activities.

4) HPV 16 L1 gene DNA in non-B conformation was found in the post-mortem blood and spleen tissue obtained at autopsy of such a sudden unexpected death without obvious cause of death 6 months after Gardasil vaccination. No scientists at the public hearing believe that psychosomatic reactions can cause such death and inflammation of the brain in these HPV-vaccinated girls. Therefore, more research must be performed on the potential toxicity of this vaccine.